
|Articles|January 20, 2015
Covance Solution Bridges Preclinical to Clinical Development
Covance Inc., the world’s most comprehensive drug development company, today announced the introduction of Covance Early Phase Development Solutions,
Advertisement
Covance has introduced its Early Phase Development Solutions, a multi-disciplined approach to early drug development that provides sponsors access to a molecule solution team made up of experts from nonclinical, clinical and regulatory disciplines. These experts will focus on the sponsor’s unique target product profile to provide ongoing continuity in strategic program design that spans nonclinical through to first-in-human ready, Phase II ready, proof-of-concept and full-development ready.
Read the full text
Advertisement
Advertisement
Advertisement
Trending on Applied Clinical Trials Online
1
AI-Enabled Sites and the Future of Trial Planning: Q&A with Liz Beatty, Inato
2
ACT Brief: CTTI Risk Myth-Busting, Hidden ePRO Exclusion Criteria, and Patient-Centered Care Models
3
Operational Pragmatism in ePRO-heavy trials
4
Could Selective Safety Data Collection Become the Industry's New Default?
5



